The Role of EMMPRIN in Perirenal Fat Invasion Clear Cell Renal Cell Carcinoma.

• Main Authors: Vira Yasmina Ramadhani, Vira, Anny Setijo Rahaju, Anny, Nila Kurniasari, Nila
• Format: Article PeerReviewed
• Language: English; Indonesian; English; English; Indonesian
• Published: Medico Legal Society
• Subjects: R Medicine; R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/122340/1/7%20ARTIKEL.pdf; https://repository.unair.ac.id/122340/2/7%20etik.pdf; https://repository.unair.ac.id/122340/4/C7.pdf; https://repository.unair.ac.id/122340/5/7%20turnitin.pdf; https://repository.unair.ac.id/122340/10/Karil%20%281%29-7.pdf; https://repository.unair.ac.id/122340/; https://medicopublication.com/index.php/ijfmt/article/view/13645
• Institution: Universitas Airlangga

Abstract Renal Cell Carcinoma (RCC) is a common malignancy of the kidney, and Clear Cell Renal Cell Carcinoma (CCRCC) is the most common type. Accurate prediction of prognosis is valuable for therapy and follow up. EMMPRIN is a transmembrane protein of the immunoglobulin family and is associated with tumour proliferation, invasion and metastasis. This study aims to prove the role of EMMPRIN in perirenal fat invasion CCRCC. This analytic observational study with a cross-sectional approach conducted in Anatomical Pathology Institute of Dr. Soetomo Hospital, Surabaya that used 44 samples of paraffin blocks from radical nephrectomy preparations for CCRCC patients at the period of January 2013-December 2018, which were divided based on perirenal fat invasion status. The analyzed was using Spearman test. EMMPRIN expression is positively correlated with perirenal fat invasiveness (p = 0.019) in clear cell renal cell carcinoma. EMMPRIN expression is related with perirenal fat invasiveness, in clear cell renal cell carcinoma.